Recent advances in understanding the pathophysiology of multiple sclerosis (MS) have made possible the development of exciting new treatment options. ...
Recent advances in understanding the pathophysiology of multiple sclerosis (MS) have made possible the development of exciting new treatment options. In the first of this five-part, virtual grand rounds series, Dr. James D. Bowen discusses current knowledge of the process of neural damage in MS and explores the possibility that available and emerging agents may have activity in neuronal preservation, in addition to their anti-inflammatory effects. In the second and third grand rounds, Dr. Clyde E. Markowitz begins by discussing strategies for incorporating small molecules into current treatment regimens in actual clinical practice, focusing especially on the importance of early diagnosis and treatment and the safety and efficacy of these new agents, then moves on to consider strategies for optimizing the use of available agents in more aggressive regimens and possible drug combinations. Advances in managing two important symptoms of MS-walking impairment and neurogenic bladder dysfunction-are the subjects of the fourth and fifth grand rounds, by Dr. Bowen and Dr. Victor Nitti, respectively. All five parts of the series include patient examples to provide hands-on illustrations of the issues involved.
Size: 268.2 MB
Price: $ 0.00
Day of release: 0000-00-0